Similarly, among the 100 HCC specimens in the validation group, the low and high COPB2 expression rates were 43% (43/100) and 57% (57/100), respectively, and the low and high YAP1 expression rates were 33% (33/100) and 67% (67/100), respectively. Here, COPB2 is linked to hepatocellular carcinoma.